Bulletin

Pharma groups to pay NHS £550m 'rebate'

NHS benefit from rebate

The National Health Service is to receive a £550m 'rebate' from the pharmaceuticals industry next year as part of a deal that drugmakers hope will spur faster adoption of new medicines in Britain. Pharma companies will pay the sum under an agreement that caps growth in the NHS budget for branded drugs, with the industry reimbursing any spending that overruns the cap. Almost £1bn has been paid since the deal was struck in 2013; this week pharma companies reached an agreement with the Department of Health to pay £550m in 2016. The sum includes £200m brought forward from the estimated rebates that would have been due in 2017 and 2018. The Association of the British Pharmaceutical Industry said it hoped the upfront payment would help overcome hurdles to the adoption of new medicines.

 

Note: News bulletin content has been provided by a third-party and is not the opinion of Santander

Other Articles

The new Apprenticeship Levy could help transport and logistics companies solve their recruitment problems and equip their workforces with…

Cornwall is a land steeped in legend but this salty business success story is no myth.

Santander Incubator social enterprise, Liverpool Girl Geeks, has secured £20k in Rosa funding to help them grow their programmes and…

Santander Incubator social enterprise, Liverpool Girl Geeks, has secured £20k in Rosa funding to help them grow their programmes and…

Travelstar European Ltd, one of the West Midlands’ leading coach hire companies, has moved to larger premises in Portland Street, Walsall,…

An experienced early years practitioner in Devon has secured the future of a local nursery by acquiring the business in addition to their…

Where Next?